Skip to main content
. 2014 Oct 23;2014:147040. doi: 10.1155/2014/147040

Figure 1.

Figure 1

Redox and inflammation biomarkers in I, II and III, IV NYHA class patients and control. Median [25%–75%] and 1.5IQR.

HHS Vulnerability Disclosure